191 related articles for article (PubMed ID: 31619506)
1. A
Wu VT; Kiriazov B; Koch KE; Gu VW; Beck AC; Borcherding N; Li T; Addo P; Wehrspan ZJ; Zhang W; Braun TA; Brown BJ; Band V; Band H; Kulak MV; Weigel RJ
Mol Cancer Res; 2020 Jan; 18(1):46-56. PubMed ID: 31619506
[TBL] [Abstract][Full Text] [Related]
2. TFAP2C regulates carbonic anhydrase XII in human breast cancer.
Franke CM; Gu VW; Grimm BG; Cassady VC; White JR; Weigel RJ; Kulak MV
Oncogene; 2020 Feb; 39(6):1290-1301. PubMed ID: 31636386
[TBL] [Abstract][Full Text] [Related]
3. Identification of target genes of transcription factor activator protein 2 gamma in breast cancer cells.
Ailan H; Xiangwen X; Daolong R; Lu G; Xiaofeng D; Xi Q; Xingwang H; Rushi L; Jian Z; Shuanglin X
BMC Cancer; 2009 Aug; 9():279. PubMed ID: 19671168
[TBL] [Abstract][Full Text] [Related]
4. EGFR Is Regulated by TFAP2C in Luminal Breast Cancer and Is a Target for Vandetanib.
De Andrade JP; Park JM; Gu VW; Woodfield GW; Kulak MV; Lorenzen AW; Wu VT; Van Dorin SE; Spanheimer PM; Weigel RJ
Mol Cancer Ther; 2016 Mar; 15(3):503-11. PubMed ID: 26832794
[TBL] [Abstract][Full Text] [Related]
5. Transcriptional regulation of the GPX1 gene by TFAP2C and aberrant CpG methylation in human breast cancer.
Kulak MV; Cyr AR; Woodfield GW; Bogachek M; Spanheimer PM; Li T; Price DH; Domann FE; Weigel RJ
Oncogene; 2013 Aug; 32(34):4043-51. PubMed ID: 22964634
[TBL] [Abstract][Full Text] [Related]
6. Fucosyltransferase 8 regulation and breast cancer suppression by transcription factor activator protein 2γ.
Ma M; Guo D; Tan Z; Du J; Guan F; Li X
Cancer Sci; 2021 Aug; 112(8):3190-3204. PubMed ID: 34036684
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of TFAP2C in invasive breast cancer correlates with a poorer response to anti-hormone therapy and reduced patient survival.
Gee JM; Eloranta JJ; Ibbitt JC; Robertson JF; Ellis IO; Williams T; Nicholson RI; Hurst HC
J Pathol; 2009 Jan; 217(1):32-41. PubMed ID: 18825690
[TBL] [Abstract][Full Text] [Related]
8. TFAP2C controls hormone response in breast cancer cells through multiple pathways of estrogen signaling.
Woodfield GW; Horan AD; Chen Y; Weigel RJ
Cancer Res; 2007 Sep; 67(18):8439-43. PubMed ID: 17875680
[TBL] [Abstract][Full Text] [Related]
9. Ku proteins interact with activator protein-2 transcription factors and contribute to ERBB2 overexpression in breast cancer cell lines.
Nolens G; Pignon JC; Koopmansch B; Elmoualij B; Zorzi W; De Pauw E; Winkler R
Breast Cancer Res; 2009; 11(6):R83. PubMed ID: 19906305
[TBL] [Abstract][Full Text] [Related]
10. Identification of primary gene targets of TFAP2C in hormone responsive breast carcinoma cells.
Woodfield GW; Chen Y; Bair TB; Domann FE; Weigel RJ
Genes Chromosomes Cancer; 2010 Oct; 49(10):948-62. PubMed ID: 20629094
[TBL] [Abstract][Full Text] [Related]
11. Expression of AP-2 transcription factors in human breast cancer correlates with the regulation of multiple growth factor signalling pathways.
Turner BC; Zhang J; Gumbs AA; Maher MG; Kaplan L; Carter D; Glazer PM; Hurst HC; Haffty BG; Williams T
Cancer Res; 1998 Dec; 58(23):5466-72. PubMed ID: 9850080
[TBL] [Abstract][Full Text] [Related]
12. Activator protein-2gamma (AP-2gamma) expression is specifically induced by oestrogens through binding of the oestrogen receptor to a canonical element within the 5'-untranslated region.
Orso F; Cottone E; Hasleton MD; Ibbitt JC; Sismondi P; Hurst HC; De Bortoli M
Biochem J; 2004 Jan; 377(Pt 2):429-38. PubMed ID: 14565844
[TBL] [Abstract][Full Text] [Related]
13. Investigating AP-2 and YY1 protein expression as a cause of high HER2 gene transcription in breast cancers with discordant HER2 gene amplification.
Powe DG; Akhtar G; Habashy HO; Abdel-Fatah T; Rakha EA; Green AR; Ellis IO
Breast Cancer Res; 2009; 11(6):R90. PubMed ID: 20025767
[TBL] [Abstract][Full Text] [Related]
14. AP-2gamma promotes proliferation in breast tumour cells by direct repression of the CDKN1A gene.
Williams CM; Scibetta AG; Friedrich JK; Canosa M; Berlato C; Moss CH; Hurst HC
EMBO J; 2009 Nov; 28(22):3591-601. PubMed ID: 19798054
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the human activator protein-2gamma (AP-2gamma) gene: control of expression by Sp1/Sp3 in breast tumour cells.
Hasleton MD; Ibbitt JC; Hurst HC
Biochem J; 2003 Aug; 373(Pt 3):925-32. PubMed ID: 12733991
[TBL] [Abstract][Full Text] [Related]
16. Activator protein-2 in carcinogenesis with a special reference to breast cancer--a mini review.
Pellikainen JM; Kosma VM
Int J Cancer; 2007 May; 120(10):2061-7. PubMed ID: 17330235
[TBL] [Abstract][Full Text] [Related]
17. Interaction of transcription factor AP-2 gamma with proto-oncogene PELP1 promotes tumorigenesis by enhancing RET signaling.
Liu J; Liu Z; Li M; Tang W; Pratap UP; Luo Y; Altwegg KA; Li X; Zou Y; Zhu H; Sareddy GR; Viswanadhapalli S; Vadlamudi RK
Mol Oncol; 2021 Apr; 15(4):1146-1161. PubMed ID: 33269540
[TBL] [Abstract][Full Text] [Related]
18. AP-2gamma induces p21 expression, arrests cell cycle, and inhibits the tumor growth of human carcinoma cells.
Li H; Goswami PC; Domann FE
Neoplasia; 2006 Jul; 8(7):568-77. PubMed ID: 16867219
[TBL] [Abstract][Full Text] [Related]
19. Transcription factor AP-2gamma is a developmentally regulated marker of testicular carcinoma in situ and germ cell tumors.
Hoei-Hansen CE; Nielsen JE; Almstrup K; Sonne SB; Graem N; Skakkebaek NE; Leffers H; Rajpert-De Meyts E
Clin Cancer Res; 2004 Dec; 10(24):8521-30. PubMed ID: 15623634
[TBL] [Abstract][Full Text] [Related]
20. Integrative molecular and functional profiling of ERBB2-amplified breast cancers identifies new genetic dependencies.
Shiu KK; Wetterskog D; Mackay A; Natrajan R; Lambros M; Sims D; Bajrami I; Brough R; Frankum J; Sharpe R; Marchio C; Horlings H; Reyal F; van der Vijver M; Turner N; Reis-Filho JS; Lord CJ; Ashworth A
Oncogene; 2014 Jan; 33(5):619-31. PubMed ID: 23334330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
